Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract Extraction

A Prospective, Multicenter, Open-label, Single-arm Clinical Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) IOL for Correction of Aphakia Following Cataract Extraction

A study to learn how well an artificial lens, called an intraocular lens (IOL), works in adults who have cataract surgery. During this type of surgery, the eye's natural lens is removed and replaced with an artificial lens to help restore vision.

The main goal of the study is to evaluate vision after the lens is placed in the eye. About one year after surgery, participants' vision will be measured to understand how clearly they can see.

The study will also look at how the lens performs over time, including how well it remains in place in the eye.

The results of this study will help provide more information about how this lens performs in adults undergoing cataract surgery.

Inclusion Criteria:

• Are able and willing to provide written informed consent, attend all scheduled visits, and comply with all trial procedures and follow-up
• Have a study eye with visually significant cataract for which phacoemulsification cataract extraction and posterior chamber IOL implantation is indicated
• Meet all other inclusion criteria outlined in the clinical study protocol

Exclusion Criteria:

• Have serious systemic disease that could increase operative risk or conditions that can confound the surgical outcome
• Within 30 days of the Screening Visit, use of systemic medications with significant ocular side effects or any medications that could confound the outcome or increase participant risk
• Meet any other exclusion criteria outlined in the clinical study protocol